Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/1995
11/14/1995US5466592 Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom
11/14/1995US5466585 Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies
11/14/1995US5466584 Oxytocin receptor and DNA coding therefor
11/10/1995CA2148301A1 Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds
11/09/1995WO1995030326A1 Neural receptor tyrosine kinase
11/09/1995WO1995030019A1 Feline immunodeficiency virus vaccine
11/09/1995WO1995030016A1 Methods for peptide synthesis and purification
11/09/1995WO1995030014A1 Bifunctional protein, preparation and use
11/09/1995WO1995030008A1 Density enhanced protein tyrosine phosphatases
11/09/1995WO1995030006A1 Leishmania major protein, nucleic acid coding therefor, and uses thereof
11/09/1995WO1995030004A1 Monoclonal antibodies which promote central nervous system remyelination
11/09/1995WO1995030003A2 Morphogenic protein-specific cell surface receptors and uses therefor
11/09/1995WO1995030000A1 Dna sequences
11/09/1995WO1995029998A1 Thermostable xylanases
11/09/1995WO1995029997A1 Use of a thermostable enzyme as a feed additive
11/09/1995WO1995029995A1 Wt1 monoclonal antibodies and methods of use therefor
11/09/1995WO1995029988A1 In vitro growth of functional islets of langerhans and in vivo uses thereof
11/09/1995WO1995029986A1 Method for controlling metallophosphate precipitation in high cell density fermentations
11/09/1995WO1995029935A1 Method for proliferating and differentiating b cells, and uses thereof
11/09/1995WO1995029699A1 Vaccine for, diagnostic assay for and method of treating parasitic hemoflagellate protozoa
11/09/1995WO1995029697A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995WO1995029686A1 Recombinant fibrin chains, fibrin and fibrin-homologs
11/09/1995DE4440118C1 Die Genexpression in coryneformen Bakterien regulierende DNA Gene expression in coryneform bacteria regulatory DNA
11/09/1995CA2690298A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995CA2189438A1 Dna sequences
11/09/1995CA2188663A1 Wt1 monoclonal antibodies and methods of use therefor
11/09/1995CA2188648A1 In vitro growth of functional islets of langerhans and in vivo uses thereof
11/09/1995CA2188647A1 Recombinant fibrin chains, fibrin and fibrin-homologs
11/09/1995CA2188558A1 Use of a thermostable enzyme as a feed additive
11/09/1995CA2187902A1 Morphogenic protein-specific cell surface receptors and uses therefor
11/09/1995CA2186365A1 Neural receptor tyrosine kinase
11/09/1995CA2165413A1 Methods for peptide synthesis and purification
11/08/1995EP0681027A2 Plasmid vector and its use for the production of heterologous proteins
11/08/1995EP0680513A1 Lysosomal targeting of immunogens
11/08/1995EP0680335A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide
11/08/1995EP0680331A1 Recombinant virus immunotherapy
11/08/1995EP0680316A1 Novel parasitic helminth proteins
11/08/1995EP0419574B1 Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same
11/08/1995EP0393051B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
11/08/1995CN1111455A Peptide inhibitors of mitogenesis and motorgenesis
11/07/1995US5464939 Highly purified protein, production and use thereof
11/07/1995US5464935 Peptide inhibitors of selectin binding
11/07/1995US5464822 Polypeptides and polypeptide analogues
11/07/1995US5464770 Artificial sweeteners
11/07/1995US5464757 Corticotropin releasing factor, genetic engineering
11/07/1995US5464756 Processes and compositions for the isolation of human relaxin
11/07/1995US5464751 Purified protein or fragment bindable with p185, translation product of neu oncogene; dimer or trimer of protein; screening for mammalian tumor with p185 on tumor cell surfaces by contacting cells with protein, detecting bound protein
11/07/1995CA1337518C Monoclonal antibodies against tnf-–, hybridomas producing them and method for the purification of tnf-–
11/02/1995WO1995029404A1 Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation
11/02/1995WO1995029252A1 Oral preparation for patients with chronic renal insufficiency and other protein metabolic diseases
11/02/1995WO1995029245A2 Btf2 complex proteins and uses thereof
11/02/1995WO1995029243A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
11/02/1995WO1995029242A1 Angiostatin and method of use for inhibition of angiogenesis
11/02/1995WO1995029239A2 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995WO1995029237A1 Cardiotrophin and uses therefor
11/02/1995WO1995029236A2 Lymphocyte activation antigens and antibodies thereto
11/02/1995WO1995029235A1 Spider neurotoxins and method of producing the same
11/02/1995WO1995029234A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines
11/02/1995WO1995029233A1 ISOLATED NUCLEIC ACID MOLECULE CODING FOR FIBROBLAST ACTIVATION PROTEIN α AND USES THEREOF
11/02/1995WO1995029193A2 Melanoma antigens
11/02/1995WO1995029188A1 Human sperm diagnostic
11/02/1995WO1995029186A1 Compositions and methods for cell transformation
11/02/1995WO1995029185A1 Novel megakaryocytic protein tyrosine kinases
11/02/1995WO1995029180A1 Porphocyanine and cnc-expanded porphyrins
11/02/1995WO1995028961A1 Remedy for rheumatoid arthritis
11/02/1995WO1995028957A2 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995WO1995028949A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995WO1995027060A3 Biologically active eph family ligands
11/02/1995EP0679718A2 Process for producing alpha-interferon
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679660A1 Antihuman tyrosinase monoclonal antibody
11/02/1995EP0679192A1 Improved recombinant production of proteins having factor viii:c activity
11/02/1995EP0679187A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv.
11/02/1995EP0679186A1 Monokine mig induced by ifn-gamma
11/02/1995EP0679185A1 Ras associated gap proteins
11/02/1995EP0679182A1 Delivery of gene products via mesangial cells
11/02/1995EP0679163A1 Growth differentiation factor-3
11/02/1995EP0679094A1 Compounds for targeting
11/02/1995EP0679089A1 Methods for promoting cartilage matrix formation
11/02/1995CA2722364A1 Melanoma antigens
11/02/1995CA2188672A1 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995CA2188543A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995CA2188397A1 Human sperm diagnostic
11/02/1995CA2188395A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995CA2188320A1 Compositions and methods for cell transformation
11/02/1995CA2188258A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines
11/02/1995CA2187920A1 Spider neurotoxins and method of producing the same
10/1995
10/31/1995US5463175 Glyphosate tolerant plants
10/31/1995US5463029 Adsorbing, eluting on cationic exchange resin, followed by same on anionic exchange resin
10/31/1995US5463026 Anti-human prohibitin antibodies
10/31/1995US5463025 Protein having human plasmin inhibiting activity
10/31/1995US5462925 Transforming growth factor β2,3
10/31/1995US5462871 Nonapeptides bind to human leukocyte antigens on cell surfaces leading to lysis by cytolytic T lymphocytes
10/31/1995CA2002516C Process for the expression of a recombinant gene
10/30/1995CA2122874A1 Neural receptor tyrosine kinase
10/26/1995WO1995028642A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
10/26/1995WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220
10/26/1995WO1995028487A2 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028483A1 Cell-cycle regulatory proteins, and uses related thereto